Abstract
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
J Priller, E M Briley, J Mansouri, W A Devane, K Mackie and C C Felder
Molecular Pharmacology August 1995, 48 (2) 288-292;